应交易所要求,美/港股行情延时15分钟展示,下载APP即可免费查看实时行情。
关闭
AVR Anteris Technologies Global (NASDAQ Uplisting/Dual Listing)
未开盘 03-12 16:00:00 EDT
6.58
-0.11
-1.64%
盘后
6.58
+0.00
0.00%
19:05 EDT
最高
6.90
最低
6.56
成交量
101.66万
今开
6.66
昨收
6.69
日振幅
5.08%
总市值
6.37亿
流通市值
6.17亿
总股本
9,685万
成交额
681.20万
换手率
1.08%
流通股本
9,376万
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
数据加载中...
北京优虎网络科技有限公司
资讯
新帖
简况
Anteris Technologies宣布2亿美元股票发行定价及美敦力投资后,盘前股价飙升25.9%
美股速递 · 01-21
Anteris Technologies宣布2亿美元股票发行定价及美敦力投资后,盘前股价飙升25.9%
Anteris Technologies Global Corp.宣布拟进行2亿美元普通股公开发行,并获得美敦力战略投资
美股速递 · 01-21
Anteris Technologies Global Corp.宣布拟进行2亿美元普通股公开发行,并获得美敦力战略投资
Anteris Technologies Global Corp - 将由销售股东提供最多910万股普通股 - SEC申报
美股速递 · 2025-11-27
Anteris Technologies Global Corp - 将由销售股东提供最多910万股普通股 - SEC申报
安特里斯科技全球公司宣布FDA批准Duravr THV全球关键试验
投资观察 · 2025-11-20
安特里斯科技全球公司宣布FDA批准Duravr THV全球关键试验
Anteris Duravr® THV在小瓣环患者中展示了良好的血流动力学,且一年内未发生瓣膜相关死亡
美股速递 · 2025-10-29
Anteris Duravr® THV在小瓣环患者中展示了良好的血流动力学,且一年内未发生瓣膜相关死亡
Anteris Technologies 宣布 Duravr® Thv 全球关键试验(“Paradigm 试验”)的首批患者治疗情况
美股速递 · 2025-10-28
Anteris Technologies 宣布 Duravr® Thv 全球关键试验(“Paradigm 试验”)的首批患者治疗情况
Anteris Technologies Global Corp - 寻求交易暂停以待资本募集提案公告
美股速递 · 2025-10-24
Anteris Technologies Global Corp - 寻求交易暂停以待资本募集提案公告
Anteris Technologies Global Corp - 预计丹麦中心的患者招募将在2025年第四季度开始
美股速递 · 2025-10-15
Anteris Technologies Global Corp - 预计丹麦中心的患者招募将在2025年第四季度开始
Anteris获得首次欧洲监管批准以启动Duravr® THV全球关键试验(“Paradigm试验”)
美股速递 · 2025-10-15
Anteris获得首次欧洲监管批准以启动Duravr® THV全球关键试验(“Paradigm试验”)
Anteris Technologies(AVR.US)获Lake Street首次覆盖,给予买入评级, 目标价20.00美元。
金融界 · 2025-01-09
Anteris Technologies(AVR.US)获Lake Street首次覆盖,给予买入评级, 目标价20.00美元。
异动解读 | AVR首次公开募股后盘中暴跌12.33%,募资增股致短期供给压力
异动解读 · 2024-12-14
异动解读 | AVR首次公开募股后盘中暴跌12.33%,募资增股致短期供给压力
澳大利亚医疗设备公司Anteris(AVR.US)IPO定价6.78美元/股 拟筹资1亿美元
智通财经 · 2024-12-10
澳大利亚医疗设备公司Anteris(AVR.US)IPO定价6.78美元/股 拟筹资1亿美元
加载更多
公司概况
公司名称:
Anteris Technologies Global (NASDAQ Uplisting/Dual Listing)
所属市场:
NASDAQ
上市日期:
--
主营业务:
Anteris Technologies Global Corp.于2024年1月29日在特拉华州注册成立。该公司是一家结构性心脏公司,致力于发现、开发和商业化创新医疗设备,旨在改善主动脉瓣狭窄患者的生活质量。
发行价格:
--
{"stockData":{"symbol":"AVR","market":"US","secType":"STK","nameCN":"Anteris Technologies Global (NASDAQ Uplisting/Dual Listing)","latestPrice":6.58,"timestamp":1773345600000,"preClose":6.69,"halted":0,"volume":1016579,"hourTrading":{"tag":"盘后","latestPrice":6.58,"preClose":6.58,"latestTime":"19:05 EDT","volume":29885,"amount":196647.22,"timestamp":1773356716623,"change":0,"changeRate":0,"amplitude":0},"delay":0,"changeRate":-0.01644245142002994,"floatShares":93757000,"shares":96849700,"eps":-2.550534,"marketStatus":"未开盘","change":-0.11,"latestTime":"03-12 16:00:00 EDT","open":6.66,"high":6.9,"low":6.56,"amount":6811959.3524402995,"amplitude":0.050822,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-2.550534,"tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1773388800000},"marketStatusCode":0,"adr":0,"listingDate":1734066000000,"exchange":"NASDAQ","adjPreClose":6.69,"preHourTrading":{"tag":"盘前","latestPrice":6.66,"preClose":6.69,"latestTime":"09:28 EDT","volume":1607,"amount":10678.233775,"timestamp":1773322081081,"change":-0.03,"changeRate":-0.004484,"amplitude":0.011958},"postHourTrading":{"tag":"盘后","latestPrice":6.58,"preClose":6.58,"latestTime":"19:05 EDT","volume":29885,"amount":196647.22,"timestamp":1773356716623,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":1.034053,"impliedVol":0.8737,"impliedVolPercentile":0.2571},"requestUrl":"/m/hq/s/AVR","defaultTab":"news","newsList":[{"id":"1185513956","title":"Anteris Technologies宣布2亿美元股票发行定价及美敦力投资后,盘前股价飙升25.9%","url":"https://stock-news.laohu8.com/highlight/detail?id=1185513956","media":"美股速递","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1185513956?lang=zh_cn&edition=full","pubTime":"2026-01-21 17:38","pubTimestamp":1768988293,"startTime":"0","endTime":"0","summary":"Anteris Technologies股价在盘前交易中大幅攀升25.9%,此前该公司公布了2亿美元股票发行的定价细节,并确认获得医疗设备巨头美敦力的战略投资。\n这一重大融资举措不仅为Anteris Technologies注入了强劲的资金支持,更通过与行业领导者美敦力的资本合作,显著提升了市场对其技术前景的信心。投资者对此反应热烈,推动股价出现显著波动。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BDGV0183.EUR","MDT","LU0162691827.USD","LU0320765489.SGD","LU2089984988.USD","IE00B3PB1722.GBP","IE00B3T34201.USD","LU2111349929.HKD","LU0211331839.USD","IE000M9KFDE8.USD","LU1983299246.USD","LU1061106388.HKD","IE00BGHQF631.EUR","BK4082","IE00BQXX3D17.EUR","LU0072461881.USD","LU2023251221.USD","AVR","BK4588","LU0314106906.USD","LU0070302665.USD","LU1506573853.SGD","LU0976567544.SGD","LU1989771016.USD","LU1244550494.USD","LU1571399168.USD","LU2112291526.USD","LU0158827948.USD","LU0211326839.USD","LU2089283258.USD","LU1244550221.USD","LU1023059063.AUD","IE00BQXX3F31.USD","LU0208291251.USD","BK4585","LU0432979614.USD","BK4533","LU0122379950.USD","LU2271345857.HKD","LU1989764748.USD","IE00B42XCP33.USD","LU0158827781.USD","IE00BVYPNW00.USD","LU0265550946.USD","LU2468319806.SGD","LU0211326755.USD","LU1291159041.SGD","LU1244550577.SGD","LU0265550359.USD","IE00BQXX3C00.GBP","LU1989764664.SGD","BK4566","LU2089284900.SGD","IE00BVYPNV92.GBP","LU1116320901.HKD","LU1116320737.USD","LU2028103732.USD","LU1057294990.SGD","IE00BFXG1179.USD","LU0496365809.HKD"],"gpt_icon":0},{"id":"1102163128","title":"Anteris Technologies Global Corp.宣布拟进行2亿美元普通股公开发行,并获得美敦力战略投资","url":"https://stock-news.laohu8.com/highlight/detail?id=1102163128","media":"美股速递","labels":["shareholding","corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1102163128?lang=zh_cn&edition=full","pubTime":"2026-01-21 05:02","pubTimestamp":1768942936,"startTime":"0","endTime":"0","summary":"Anteris Technologies Global Corp. 近日披露了一项重要资本运作计划。该公司宣布,拟公开市场发行普通股,目标融资规模高达2亿美元。与此同时,全球医疗技术巨头美敦力(Medtronic)已承诺对其进行战略投资,此举将为公司未来发展注入强劲动力。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4082","AVR"],"gpt_icon":0},{"id":"1109513896","title":"Anteris Technologies Global Corp - 将由销售股东提供最多910万股普通股 - SEC申报","url":"https://stock-news.laohu8.com/highlight/detail?id=1109513896","media":"美股速递","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1109513896?lang=zh_cn&edition=full","pubTime":"2025-11-27 05:38","pubTimestamp":1764193088,"startTime":"0","endTime":"0","summary":"Anteris Technologies Global Corp - 将由销售股东提供最多910万股普通股 - SEC申报","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["AVR","BK4082"],"gpt_icon":0},{"id":"1145132209","title":"安特里斯科技全球公司宣布FDA批准Duravr THV全球关键试验","url":"https://stock-news.laohu8.com/highlight/detail?id=1145132209","media":"投资观察","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1145132209?lang=zh_cn&edition=full","pubTime":"2025-11-20 00:23","pubTimestamp":1763569381,"startTime":"0","endTime":"0","summary":"11月3日 - 安特里斯科技全球公司:*FDA批准Duravr THV全球关键试验*。进一步公司报道:AVR.O","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4082","AVR"],"gpt_icon":0},{"id":"1160436362","title":"Anteris Duravr® THV在小瓣环患者中展示了良好的血流动力学,且一年内未发生瓣膜相关死亡","url":"https://stock-news.laohu8.com/highlight/detail?id=1160436362","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1160436362?lang=zh_cn&edition=full","pubTime":"2025-10-29 06:09","pubTimestamp":1761689348,"startTime":"0","endTime":"0","summary":"Anteris Duravr® THV在小瓣环患者中展示了良好的血流动力学,且一年内未发生瓣膜相关死亡。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4082","AVR"],"gpt_icon":0},{"id":"1155538760","title":"Anteris Technologies 宣布 Duravr® Thv 全球关键试验(“Paradigm 试验”)的首批患者治疗情况","url":"https://stock-news.laohu8.com/highlight/detail?id=1155538760","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1155538760?lang=zh_cn&edition=full","pubTime":"2025-10-28 05:44","pubTimestamp":1761601486,"startTime":"0","endTime":"0","summary":"Anteris Technologies 宣布 Duravr® Thv 全球关键试验(“Paradigm 试验”)的首批患者治疗情况","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["AVR","BK4082"],"gpt_icon":0},{"id":"1199476263","title":"Anteris Technologies Global Corp - 寻求交易暂停以待资本募集提案公告","url":"https://stock-news.laohu8.com/highlight/detail?id=1199476263","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1199476263?lang=zh_cn&edition=full","pubTime":"2025-10-24 06:50","pubTimestamp":1761259809,"startTime":"0","endTime":"0","summary":"Anteris Technologies Global Corp - 寻求交易暂停以待资本募集提案公告","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["AVR","BK4082"],"gpt_icon":0},{"id":"1113345988","title":"Anteris Technologies Global Corp - 预计丹麦中心的患者招募将在2025年第四季度开始","url":"https://stock-news.laohu8.com/highlight/detail?id=1113345988","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1113345988?lang=zh_cn&edition=full","pubTime":"2025-10-15 21:19","pubTimestamp":1760534349,"startTime":"0","endTime":"0","summary":"Anteris Technologies Global Corp - 预计丹麦中心的患者招募将在2025年第四季度开始","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4082","AVR"],"gpt_icon":0},{"id":"1120072622","title":"Anteris获得首次欧洲监管批准以启动Duravr® THV全球关键试验(“Paradigm试验”)","url":"https://stock-news.laohu8.com/highlight/detail?id=1120072622","media":"美股速递","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1120072622?lang=zh_cn&edition=full","pubTime":"2025-10-15 21:19","pubTimestamp":1760534348,"startTime":"0","endTime":"0","summary":"Anteris获得首次欧洲监管批准以启动Duravr® THV全球关键试验(“Paradigm试验”)","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4082","AVR"],"gpt_icon":0},{"id":"2502870517","title":"Anteris Technologies(AVR.US)获Lake Street首次覆盖,给予买入评级, 目标价20.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2502870517","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2502870517?lang=zh_cn&edition=full","pubTime":"2025-01-09 01:41","pubTimestamp":1736358102,"startTime":"0","endTime":"0","summary":"Anteris Technologies(AVR.US)获Lake Street首次覆盖,给予买入评级, 目标价20.00美元。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/01/09014147279955.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["AVR"],"gpt_icon":0},{"id":"1179521583","title":"异动解读 | AVR首次公开募股后盘中暴跌12.33%,募资增股致短期供给压力","url":"https://stock-news.laohu8.com/highlight/detail?id=1179521583","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1179521583?lang=zh_cn&edition=full","pubTime":"2024-12-14 03:34","pubTimestamp":1734118456,"startTime":"0","endTime":"0","summary":"心脏瓣膜公司Anteris Technologies Global (AVR) 在纳斯达克上市首日当日暴跌12.33%,引发市场广泛关注。\nAVR当日在纳斯达克进行首次公开募股,发行价为每股6美元,共募集约8,900万美元资金。但开盘后股价即呈现大跌,盘中一度下探至5.26美元。\n市场分析认为,AVR首次公开募股增发新股导致股票供给激增,短期内形成供给压力拖累股价下跌,同时或有投机资金涌入、出货操作亦加剧了股价震荡。投资者对未来发展前景存在分歧,市场情绪转差致股价重挫。预计供需矛盾在未来将得到缓解,股价震荡将趋于平稳。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"异动解读 | AVR首次公开募股后盘中暴跌12.33%,募资增股致短期供给压力","news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["AVR"],"gpt_icon":0},{"id":"2490065371","title":"澳大利亚医疗设备公司Anteris(AVR.US)IPO定价6.78美元/股 拟筹资1亿美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2490065371","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2490065371?lang=zh_cn&edition=full","pubTime":"2024-12-10 15:45","pubTimestamp":1733816700,"startTime":"0","endTime":"0","summary":"智通财经APP获悉,澳大利亚的人工心脏瓣膜制造商Anteris Technologies周一宣布了其 IPO 条款。该公司计划以每股6.78美元的价格发行1,480万股股票,以筹集1亿美元资金。按照拟议价格,Anteris Technologies的市值将达到2.44亿美元。该公司的股票目前在澳大利亚证券交易所上市,代码为“AVR”。Anteris是一家专注于主动脉狭窄患者的结构性心脏公司。Anteris于2024年2月14日秘密提交了申请。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1222675.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["159873","AVR"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.anteristech.com","stockEarnings":[{"period":"1week","weight":0.0395},{"period":"1month","weight":0.1364},{"period":"3month","weight":0.3213},{"period":"6month","weight":0.1813},{"period":"1year","weight":-0.0962},{"period":"ytd","weight":0.3186}],"compareEarnings":[{"period":"1week","weight":-0.0224},{"period":"1month","weight":-0.0377},{"period":"3month","weight":-0.023},{"period":"6month","weight":0.0132},{"period":"1year","weight":0.1918},{"period":"ytd","weight":-0.0233}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Anteris Technologies Global Corp.于2024年1月29日在特拉华州注册成立。该公司是一家结构性心脏公司,致力于发现、开发和商业化创新医疗设备,旨在改善主动脉瓣狭窄患者的生活质量。","exchange":"NASDAQ","name":"Anteris Technologies Global (NASDAQ Uplisting/Dual Listing)","nameEN":"Anteris Technologies Global (NASDAQ Uplisting/Dual Listing)"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.36.2","shortVersion":"4.36.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Anteris Technologies Global (NASDAQ Uplisting/Dual Listing)(AVR)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Anteris Technologies Global (NASDAQ Uplisting/Dual Listing)(AVR)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Anteris Technologies Global (NASDAQ Uplisting/Dual Listing),AVR,Anteris Technologies Global (NASDAQ Uplisting/Dual Listing)股票,Anteris Technologies Global (NASDAQ Uplisting/Dual Listing)股票老虎,Anteris Technologies Global (NASDAQ Uplisting/Dual Listing)股票老虎国际,Anteris Technologies Global (NASDAQ Uplisting/Dual Listing)行情,Anteris Technologies Global (NASDAQ Uplisting/Dual Listing)股票行情,Anteris Technologies Global (NASDAQ Uplisting/Dual Listing)股价,Anteris Technologies Global (NASDAQ Uplisting/Dual Listing)股市,Anteris Technologies Global (NASDAQ Uplisting/Dual Listing)股票价格,Anteris Technologies Global (NASDAQ Uplisting/Dual Listing)股票交易,Anteris Technologies Global (NASDAQ Uplisting/Dual Listing)股票购买,Anteris Technologies Global (NASDAQ Uplisting/Dual Listing)股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Anteris Technologies Global (NASDAQ Uplisting/Dual Listing)(AVR)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Anteris Technologies Global (NASDAQ Uplisting/Dual Listing)(AVR)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}